Hydrazine sulfate CAS: 10034-93-2

CAS NO: 10034-93-2
Hydrazine sulfate
Chemical Name:
Hydrazine sulfate, hydrazinium sulfate

Molecular Formula:
N2H4•H2SO4

Formula Weight:
130.12 g/mol (anhydrous)

CAS No:
10034-93-2
Description Review
Description
Hydrazine sulfate, also known as hydrazinium sulfate, is a chemical compound with the molecular formula N2H4·H2SO4. It is a salt that is commonly used as a reducing agent, a flame retardant, and an anticancer agent. In this article, we will explore the various aspects of hydrazine sulfate, including its chemical properties, health benefits, potential effects, mechanisms, safety, and dosage information.

Hydrazine sulfate, N2H4•H2SO4, hydrazinium sulfate, reducing agent, flame retardant, anticancer agent, cancer treatment, hydrazine sulphate

Health Benefits: Hydrazine sulfate is primarily used as an anticancer agent, and has been observed to have a positive effect on the appetite, mood, and quality of life of cancer patients. It is also sometimes used to treat liver cirrhosis and as an additive in rocket fuel.

Potential Effects: Hydrazine sulfate has been observed to increase appetite in cancer patients, which can help improve their nutritional status and overall quality of life. It has also been shown to improve mood and reduce the severity of depression in some people.

Mechanisms: The exact mechanisms of action of hydrazine sulfate are not fully understood, but it is believed to act as a metabolic stimulant, reducing the levels of lactic acid in the body and increasing the activity of certain enzymes. It may also help reduce the inflammation associated with cancer and improve the immune system's ability to fight off tumors.

Safety: Hydrazine sulfate is a highly toxic and flammable chemical that should be handled with extreme care. It can cause skin irritation and burns, as well as nausea, vomiting, and other symptoms of acute poisoning. Long-term exposure to hydrazine sulfate has been associated with an increased risk of liver and lung cancer, as well as reproductive and developmental disorders.

Side-Effects: Some of the common side effects associated with hydrazine sulfate include nausea, vomiting, dizziness, and headaches. More serious side effects may include liver and kidney damage, skin rash, and respiratory problems.

Dosage Information: The recommended dosage of hydrazine sulfate varies depending on the individual needs and characteristics of the patient, as well as the specific condition being treated. It is important to consult with a healthcare provider or qualified professional before taking any medication or supplement.

In conclusion, hydrazine sulfate is a highly toxic chemical compound with potential health benefits as an anticancer agent and metabolic stimulant. However, it should be used with caution and under the supervision of a qualified healthcare professional. Patients should also be aware of the potential side effects and long-term risks associated with this substance.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code